APA (7th ed.) Citation

Berger, A. (2020). NY-BR-1 specific CAR+ T cells engineered by S/MAR vectors prove effectiveness in pre-clinical models of breast cancer.

Chicago Style (17th ed.) Citation

Berger, Aileen. NY-BR-1 Specific CAR+ T Cells Engineered by S/MAR Vectors Prove Effectiveness in Pre-clinical Models of Breast Cancer. Heidelberg, 2020.

MLA (9th ed.) Citation

Berger, Aileen. NY-BR-1 Specific CAR+ T Cells Engineered by S/MAR Vectors Prove Effectiveness in Pre-clinical Models of Breast Cancer. 2020.